“…Congenital LQTS (ORPHA:768) is a clinical disorder of genetic origin characterized by delayed repolarisation of the myocardium, electrocardiographic QT prolongation, and increased risk of syncope, seizures, and SCD caused by polymorphic ventricular tachycardia, known as Torsades des Pointes (TdP) [3]. To date, pathogenic variants associated with LQTS have been identified in 19 autosomal-recessive pattern (TRDN), and two following both autosomal-dominant andrecessive patterns (KCNQ1 and KCNE1) [4,5]. LQT1, LQT2, and LQT3 genotypes comprise more than 95% of the patients with genotype-positive LQTS and approximately 75% of all patients with LQTS [6].…”